Lv11
40 积分 2023-11-29 加入
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial
1小时前
已完结
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
1个月前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer
2个月前
已完结
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study
2个月前
已完结
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
2个月前
已完结
Inducing vascular normalization: A promising strategy for immunotherapy
2个月前
已完结
Hypofractionated Radiation Therapy Combined With Weekly Chemotherapy in Patients With Unresectable or Recurrent Thymic Epithelial Tumor: A Prospective, Single-Arm Phase 2 Study (GASTO-1042)
2个月前
已完结
Intensity Modulated Radiation Therapy for Pleural Recurrence of Thymoma: A Prospective Phase 2 Study
2个月前
已完结
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
3个月前
已完结
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
3个月前
已完结
皖公网安备34019202002308
